Loomis Sayles & CO L P Ultragenyx Pharmaceutical Inc. Transaction History
Loomis Sayles & CO L P
- $69.2 Billion
- Q1 2025
A detailed history of Loomis Sayles & CO L P transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Loomis Sayles & CO L P holds 561,479 shares of RARE stock, worth $15.4 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
561,479Holding current value
$15.4 Million% of portfolio
0.03%Shares
6 transactions
Others Institutions Holding RARE
# of Institutions
336Shares Held
89.4MCall Options Held
1.08MPut Options Held
1.04M-
Vanguard Group Inc Valley Forge, PA10MShares$273 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$153 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.16MShares$114 Million0.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.22MShares$88 Million0.01% of portfolio
-
State Street Corp Boston, MA2.62MShares$71.6 Million0.0% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $1.91B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...